Study reveals the impact of malicious bots on public health communication during COVID-19

The information environment in Finland during the coronavirus pandemic was exceptional and intense in many ways. The spread of disinformation and the number of actors involved reached unprecedented levels.

Karuna Therapeutics files for FDA approval for schizophrenia treatment – Pharmaceutical Technology

KarXT is providing a novel approach to treatment by not directly blocking dopamine receptors. Credit: Soloveva Anastasiia via www.shutterstock.com. Karuna Therapeutics has announced the submission

September 29, 2023

Jim Wilson secures $100M for global approach aimed at reviving gene therapy field

A gene therapy pioneer thinks he has a solution to the field’s struggle to commercialize breakthrough cures: Go global. Jim Wilson’s Philadelphia-based company GemmaBio on

October 9, 2024

How has the prevalence of psychological distress in the adult population of England changed since 2020?

Researchers estimated patterns of psychological distress.

July 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.